Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3

M Pazos, D Siccardi, K L Mumy, J D Bien, S Louie, H N Shi, K Gronert, Randall J Mrsny, B A McCormick

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Neutrophil transmigration across mucosal surfaces contributes to dysfunction of epithelial barrier properties, a characteristic underlying many mucosal inflammatory diseases. Thus, insight into the directional movement of neutrophils across epithelial barriers will provide important information relating to the mechanisms of such inflammatory disorders. The eicosanoid hepoxilin A(3), an endogenous product of 12-lipoxygenase activity, is secreted from the apical surface of the epithelial barrier and establishes a chemotactic gradient to guide neutrophils from the submucosa across epithelia to the luminal site of an inflammatory stimulus, the final step in neutrophil recruitment. Currently, little is known regarding how hepoxilin A(3) is secreted from the intestinal epithelium during an inflammatory insult. In this study, we reveal that hepoxilin A(3) is a substrate for the apical efflux ATP-binding protein transporter multidrug resistance-associated protein 2 (MRP2). Moreover, using multiple in vitro and in vivo models, we show that induction of intestinal inflammation profoundly up-regulates apical expression of MRP2, and that interfering with hepoxilin A(3) synthesis and/or inhibition of MRP2 function results in a marked reduction in inflammation and severity of disease. Lastly, examination of inflamed intestinal epithelia in human biopsies revealed up-regulation of MRP2. Thus, blocking hepoxilin A(3) synthesis and/or inhibiting MRP2 may lead to the development of new therapeutic strategies for the treatment of epithelial-associated inflammatory conditions.
Original languageEnglish
Pages (from-to)8044-8052
Number of pages9
JournalThe Journal of Immunology
Volume181
Issue number11
Publication statusPublished - 1 Dec 2008

Fingerprint

Multiple Drug Resistance
Inflammation
Neutrophils
Intestinal Mucosa
Up-Regulation
Arachidonate 12-Lipoxygenase
Eicosanoids
Neutrophil Infiltration
Carrier Proteins
Epithelium
Adenosine Triphosphate
8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid
multidrug resistance-associated protein 2
Biopsy

Cite this

Pazos, M., Siccardi, D., Mumy, K. L., Bien, J. D., Louie, S., Shi, H. N., ... McCormick, B. A. (2008). Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3. The Journal of Immunology, 181(11), 8044-8052.

Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3. / Pazos, M; Siccardi, D; Mumy, K L; Bien, J D; Louie, S; Shi, H N; Gronert, K; Mrsny, Randall J; McCormick, B A.

In: The Journal of Immunology, Vol. 181, No. 11, 01.12.2008, p. 8044-8052.

Research output: Contribution to journalArticle

Pazos, M, Siccardi, D, Mumy, KL, Bien, JD, Louie, S, Shi, HN, Gronert, K, Mrsny, RJ & McCormick, BA 2008, 'Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3', The Journal of Immunology, vol. 181, no. 11, pp. 8044-8052.
Pazos, M ; Siccardi, D ; Mumy, K L ; Bien, J D ; Louie, S ; Shi, H N ; Gronert, K ; Mrsny, Randall J ; McCormick, B A. / Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3. In: The Journal of Immunology. 2008 ; Vol. 181, No. 11. pp. 8044-8052.
@article{f18fed9a419a4afea489cdf00e970f8b,
title = "Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3",
abstract = "Neutrophil transmigration across mucosal surfaces contributes to dysfunction of epithelial barrier properties, a characteristic underlying many mucosal inflammatory diseases. Thus, insight into the directional movement of neutrophils across epithelial barriers will provide important information relating to the mechanisms of such inflammatory disorders. The eicosanoid hepoxilin A(3), an endogenous product of 12-lipoxygenase activity, is secreted from the apical surface of the epithelial barrier and establishes a chemotactic gradient to guide neutrophils from the submucosa across epithelia to the luminal site of an inflammatory stimulus, the final step in neutrophil recruitment. Currently, little is known regarding how hepoxilin A(3) is secreted from the intestinal epithelium during an inflammatory insult. In this study, we reveal that hepoxilin A(3) is a substrate for the apical efflux ATP-binding protein transporter multidrug resistance-associated protein 2 (MRP2). Moreover, using multiple in vitro and in vivo models, we show that induction of intestinal inflammation profoundly up-regulates apical expression of MRP2, and that interfering with hepoxilin A(3) synthesis and/or inhibition of MRP2 function results in a marked reduction in inflammation and severity of disease. Lastly, examination of inflamed intestinal epithelia in human biopsies revealed up-regulation of MRP2. Thus, blocking hepoxilin A(3) synthesis and/or inhibiting MRP2 may lead to the development of new therapeutic strategies for the treatment of epithelial-associated inflammatory conditions.",
author = "M Pazos and D Siccardi and Mumy, {K L} and Bien, {J D} and S Louie and Shi, {H N} and K Gronert and Mrsny, {Randall J} and McCormick, {B A}",
year = "2008",
month = "12",
day = "1",
language = "English",
volume = "181",
pages = "8044--8052",
journal = "The Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3

AU - Pazos, M

AU - Siccardi, D

AU - Mumy, K L

AU - Bien, J D

AU - Louie, S

AU - Shi, H N

AU - Gronert, K

AU - Mrsny, Randall J

AU - McCormick, B A

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Neutrophil transmigration across mucosal surfaces contributes to dysfunction of epithelial barrier properties, a characteristic underlying many mucosal inflammatory diseases. Thus, insight into the directional movement of neutrophils across epithelial barriers will provide important information relating to the mechanisms of such inflammatory disorders. The eicosanoid hepoxilin A(3), an endogenous product of 12-lipoxygenase activity, is secreted from the apical surface of the epithelial barrier and establishes a chemotactic gradient to guide neutrophils from the submucosa across epithelia to the luminal site of an inflammatory stimulus, the final step in neutrophil recruitment. Currently, little is known regarding how hepoxilin A(3) is secreted from the intestinal epithelium during an inflammatory insult. In this study, we reveal that hepoxilin A(3) is a substrate for the apical efflux ATP-binding protein transporter multidrug resistance-associated protein 2 (MRP2). Moreover, using multiple in vitro and in vivo models, we show that induction of intestinal inflammation profoundly up-regulates apical expression of MRP2, and that interfering with hepoxilin A(3) synthesis and/or inhibition of MRP2 function results in a marked reduction in inflammation and severity of disease. Lastly, examination of inflamed intestinal epithelia in human biopsies revealed up-regulation of MRP2. Thus, blocking hepoxilin A(3) synthesis and/or inhibiting MRP2 may lead to the development of new therapeutic strategies for the treatment of epithelial-associated inflammatory conditions.

AB - Neutrophil transmigration across mucosal surfaces contributes to dysfunction of epithelial barrier properties, a characteristic underlying many mucosal inflammatory diseases. Thus, insight into the directional movement of neutrophils across epithelial barriers will provide important information relating to the mechanisms of such inflammatory disorders. The eicosanoid hepoxilin A(3), an endogenous product of 12-lipoxygenase activity, is secreted from the apical surface of the epithelial barrier and establishes a chemotactic gradient to guide neutrophils from the submucosa across epithelia to the luminal site of an inflammatory stimulus, the final step in neutrophil recruitment. Currently, little is known regarding how hepoxilin A(3) is secreted from the intestinal epithelium during an inflammatory insult. In this study, we reveal that hepoxilin A(3) is a substrate for the apical efflux ATP-binding protein transporter multidrug resistance-associated protein 2 (MRP2). Moreover, using multiple in vitro and in vivo models, we show that induction of intestinal inflammation profoundly up-regulates apical expression of MRP2, and that interfering with hepoxilin A(3) synthesis and/or inhibition of MRP2 function results in a marked reduction in inflammation and severity of disease. Lastly, examination of inflamed intestinal epithelia in human biopsies revealed up-regulation of MRP2. Thus, blocking hepoxilin A(3) synthesis and/or inhibiting MRP2 may lead to the development of new therapeutic strategies for the treatment of epithelial-associated inflammatory conditions.

UR - http://www.scopus.com/inward/record.url?scp=58149306029&partnerID=8YFLogxK

UR - http://www.jimmunol.org/content/181/11/8044.abstract

M3 - Article

VL - 181

SP - 8044

EP - 8052

JO - The Journal of Immunology

JF - The Journal of Immunology

SN - 0022-1767

IS - 11

ER -